111 related articles for article (PubMed ID: 28385889)
1. Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.
Mulinta R; Yao SYM; Ng AML; Cass CE; Young JD
J Biol Chem; 2017 Jun; 292(23):9505-9522. PubMed ID: 28385889
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.
Zhang J; Tackaberry T; Ritzel MW; Raborn T; Barron G; Baldwin SA; Young JD; Cass CE
Biochem J; 2006 Mar; 394(Pt 2):389-98. PubMed ID: 16271041
[TBL] [Abstract][Full Text] [Related]
3. Research Progress on hCNT3 Structure/Function and Nucleoside Anticancer Drugs.
Yue X; Zhang X; Zhang D; Zhang Z; Tang L; Ou Z; Cao Y; Li J; Li Y; Liang L; Liu W; Hu J
Curr Protein Pept Sci; 2024; 25(2):120-136. PubMed ID: 37670708
[TBL] [Abstract][Full Text] [Related]
4. Emerging Roles of Nucleoside Transporters.
Pastor-Anglada M; Pérez-Torras S
Front Pharmacol; 2018; 9():606. PubMed ID: 29928232
[TBL] [Abstract][Full Text] [Related]
5. Concentrative Nucleoside Transporter, CNT, Results in Selective Toxicity of Toyocamycin against Candida albicans.
Ojima Y; Yokota N; Tanibata Y; Nerome S; Azuma M
Microbiol Spectr; 2022 Aug; 10(4):e0113822. PubMed ID: 35913167
[TBL] [Abstract][Full Text] [Related]
6. It takes two to transport via an elevator.
Byrne B
Cell Res; 2017 Aug; 27(8):965-966. PubMed ID: 28685771
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å.
Johnson ZL; Cheong CG; Lee SY
Nature; 2012 Mar; 483(7390):489-93. PubMed ID: 22407322
[TBL] [Abstract][Full Text] [Related]
8. Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice.
Persaud AK; Bernier MC; Massey MA; Agrawal S; Kaur T; Nayak D; Xie Z; Weadick B; Raj R; Hill K; Abbott N; Joshi A; Anabtawi N; Bryant C; Somogyi A; Cruz-Monserrate Z; Amari F; Coppola V; Sparreboom A; Baker SD; Unadkat JD; Phelps MA; Govindarajan R
Nat Commun; 2023 Jun; 14(1):3175. PubMed ID: 37264059
[TBL] [Abstract][Full Text] [Related]
9. 1-Methylpyridinium-4-(4-phenylmethanethiosulfonate) iodide, MTS-MPP+, a novel scanning cysteine accessibility method (SCAM) reagent for monoamine transporter studies.
Gallardo-Godoy A; Torres-Altoro MI; White KJ; Barker EL; Nichols DE
Bioorg Med Chem; 2007 Jan; 15(1):305-11. PubMed ID: 17064910
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein topology mapping by the substituted cysteine accessibility method (SCAM(TM)): application to lipid-specific membrane protein topogenesis.
Bogdanov M; Zhang W; Xie J; Dowhan W
Methods; 2005 Jun; 36(2):148-71. PubMed ID: 15894490
[TBL] [Abstract][Full Text] [Related]
11. Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants.
Pascual JM; Wang D; Yang R; Shi L; Yang H; De Vivo DC
J Biol Chem; 2008 Jun; 283(24):16732-42. PubMed ID: 18387950
[TBL] [Abstract][Full Text] [Related]
12. Topological analyses of the L-lysine exporter LysO reveal a critical role for a conserved pair of intramembrane solvent-exposed acidic residues.
Dubey S; Majumder P; Penmatsa A; Sardesai AA
J Biol Chem; 2021 Oct; 297(4):101168. PubMed ID: 34487760
[TBL] [Abstract][Full Text] [Related]
13. An ab Initio structural model of a nucleoside permease predicts functionally important residues.
Valdés R; Arastu-Kapur S; Landfear SM; Shinde U
J Biol Chem; 2009 Jul; 284(28):19067-76. PubMed ID: 19429678
[TBL] [Abstract][Full Text] [Related]
14. Insight into the mechanism of H
Weng J; Zhou X; Wiriyasermkul P; Ren Z; Chen K; Gil-Iturbe E; Zhou M; Quick M
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2302799120. PubMed ID: 37549264
[TBL] [Abstract][Full Text] [Related]
15. Antiviral drug recognition and elevator-type transport motions of CNT3.
Wright NJ; Zhang F; Suo Y; Kong L; Yin Y; Fedor JG; Sharma K; Borgnia MJ; Im W; Lee SY
Nat Chem Biol; 2024 Feb; ():. PubMed ID: 38418906
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into the human SID1 transmembrane family member 2 reveals its lipid hydrolytic activity.
Qian D; Cong Y; Wang R; Chen Q; Yan C; Gong D
Nat Commun; 2023 Jun; 14(1):3568. PubMed ID: 37322007
[TBL] [Abstract][Full Text] [Related]
17. Author Correction: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice.
Persaud AK; Bernier MC; Massey MA; Agrawal S; Kaur T; Nayak D; Xie Z; Weadick B; Raj R; Hill K; Abbott N; Joshi A; Anabtawi N; Bryant C; Somogyi A; Cruz-Monserrate Z; Amari F; Coppola V; Sparreboom A; Baker SD; Unadkat JD; Phelps MA; Govindarajan R
Nat Commun; 2023 Jun; 14(1):3335. PubMed ID: 37286564
[No Abstract] [Full Text] [Related]
18. The last two transmembrane helices in the APC-type FurE transporter act as an intramolecular chaperone essential for concentrative ER-exit.
Pyrris Y; Papadaki GF; Mikros E; Diallinas G
Microb Cell; 2024; 11():1-15. PubMed ID: 38225947
[TBL] [Abstract][Full Text] [Related]
19. SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo.
Pettersson H; Zarnegar B; Westin A; Persson V; Peuckert C; Jonsson J; Hallgren J; Kullander K
Sci Rep; 2017 Apr; 7(1):1085. PubMed ID: 28439090
[TBL] [Abstract][Full Text] [Related]
20. Virtual Clinical Studies to Examine the Probability Distribution of the AUC at Target Tissues Using Physiologically-Based Pharmacokinetic Modeling: Application to Analyses of the Effect of Genetic Polymorphism of Enzymes and Transporters on Irinotecan Induced Side Effects.
Toshimoto K; Tomaru A; Hosokawa M; Sugiyama Y
Pharm Res; 2017 Aug; 34(8):1584-1600. PubMed ID: 28397089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
